PropertyValue
?:abstract
  • The COVID-19 pandemic has affected more than 38 million people world-wide by person to person transmission of the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). Therapeutic and preventative strategies for SARS-CoV-2 remains a significant challenge. Within the past several months, effective treatment options have emerged and now include repurposed antivirals, corticosteroids and virus-specific antibodies. The latter has included convalescence plasma and monoclonal antibodies. Complete viral eradication will be achieved through an effective, safe and preventative vaccine. To now provide a comprehensive summary for each of the pharmacotherapeutics and preventative strategies being offered or soon to be developed for SARS-CoV-2. [Image: see text]
?:creator
?:doi
  • 10.1007/s11481-020-09968-x
?:doi
?:journal
  • J_Neuroimmune_Pharmacol
?:license
  • no-cc
?:pdf_json_files
  • document_parses/pdf_json/270c82bc779f6642284fc8f3e66131281d502cef.json
?:pmc_json_files
  • document_parses/pmc_json/PMC7785334.xml.json
?:pmcid
?:pmid
?:pmid
  • 33403500.0
?:publication_isRelatedTo_Disease
?:sha_id
?:source
  • Medline; PMC
?:title
  • Pharmacotherapeutics of SARS-CoV-2 Infections
?:type
?:year
  • 2021-01-06

Metadata

Anon_0  
<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://purl.org/net/provenance/ns#DataItem>
<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/2004/03/trix/rdfg-1/Graph>
<http://xmlns.com/foaf/0.1/primaryTopic> <https://research.tib.eu/covid-19/entity/luf8yelu>
<http://xmlns.com/foaf/0.1/topic> Anon_0
<http://www.ontologydesignpatterns.org/cp/owl/informationrealization.owl#realizes> <https://research.tib.eu/covid-19/data/entity/luf8yelu>
<http://purl.org/net/provenance/ns#createdBy>
Anon_1   (more)
expand all